CASC3 and neuropathy: Despite being sufficient to completely reverse the effects of BTZ on caspase-3 activity, the pre-treatment with Z-VAD-FMK had no effect on the BTZ-induced reduction in neurite outgrowth (Fig. 3E), and we therefore conclude that the neuropathy induced by BTZ in human neurons is independent of caspase activity.